ÂÜÀòÂÒÂ×

Erica Evans is currently serving as the Vice President of Biology and Translational Medicine at MOMA Therapeutics, starting in January 2020. Prior to their current role, Erica held various leadership positions at Blueprint Medicines from 2012 to December 2019, including Vice President of Cancer Drivers, Senior Director of Biology, and Director of Biology. Before Blueprint Medicines, Erica worked at Celgene Avilomics Research and Avila Therapeutics as a Principal Scientist. Erica began their career as a Scientist II at GPC Biotech from October 2002 to May 2007. Erica holds a PhD in Molecular Cancer Biology from Duke University and a BA in Biology from Harvard University.